Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

[Combinations of bronchodilators in COPD therapy--"fashionable" or rule?].

Mihălţan F.

Pneumologia. 2013 Jul-Sep;62(3):172-5. Review. Romanian.

PMID:
24274002
2.

Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease.

Sethi S, Cote C.

Curr Clin Pharmacol. 2011 Feb;6(1):48-61. Review.

PMID:
21235463
4.

Inhaled therapy for stable chronic obstructive pulmonary disease.

Antoniu SA, Mihaescu T, Donner CF.

Expert Opin Pharmacother. 2007 Apr;8(6):777-85. Review.

PMID:
17425473
5.

Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?

Baloira A.

Expert Rev Respir Med. 2013 Apr;7(2 Suppl):17-24. doi: 10.1586/ers.13.18. Review.

PMID:
23551020
6.

Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?

Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.

Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Review.

PMID:
21714776
7.

Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?

Restrepo RD.

Respir Care. 2007 Sep;52(9):1159-73; discussion 1173-5. Review.

8.

Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Rossi A, Khirani S, Cazzola M.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):521-9. Review.

9.

[COPD treatment by drugs].

Nafti S.

Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S58-10S60. French. No abstract available.

PMID:
17127967
10.

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805.

11.

[Triple therapy in chronic obstructive pulmonary disease].

Baloira A.

Arch Bronconeumol. 2010;46 Suppl 8:25-30. doi: 10.1016/S0300-2896(10)70064-8. Review. Spanish.

12.

How far is real life from COPD therapy guidelines? An Italian observational study.

Corrado A, Rossi A.

Respir Med. 2012 Jul;106(7):989-97. doi: 10.1016/j.rmed.2012.03.008.

13.
14.

The future of combining inhaled drugs for COPD.

Bjerg A, Lundbäck B, Lötvall J.

Curr Opin Pharmacol. 2012 Jun;12(3):252-5. doi: 10.1016/j.coph.2012.03.004. Review.

PMID:
22465638
15.

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.

16.

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.

Ohar JA, Donohue JF.

Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Review.

PMID:
20496301
18.

[Medical treatment of COPD].

Vestbo J, Titlestad IL.

Ugeskr Laeger. 2013 Apr 29;175(18):1261-4. Review. Danish.

PMID:
23651802
19.

[Pharmacological management of stable COPD].

Rauscher H.

Wien Med Wochenschr. 2005 Mar;155(5-6):95-100. Review. German.

PMID:
15884489
20.

Future of chronic obstructive pulmonary disease management.

D'Urzo A, Vogelmeier C.

Expert Rev Respir Med. 2012 Jun;6(3):285-99. doi: 10.1586/ers.12.20. Review.

PMID:
22788943

Supplemental Content

Support Center